<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00766623</url>
  </required_header>
  <id_info>
    <org_study_id>NL23651.081.08</org_study_id>
    <secondary_id>empef, abr23651, 08/10 EMPEF</secondary_id>
    <nct_id>NCT00766623</nct_id>
  </id_info>
  <brief_title>Elucidation and Monitoring Postprandial Endothelial Function</brief_title>
  <acronym>EMPEF</acronym>
  <official_title>Elucidation and Monitoring Postprandial Endothelial Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wageningen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Top Institute Food and Nutrition</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Wageningen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this study is to evaluate the effect of a high fat challenge on several
      measures of endothelial function. The secondary aim of this study is to elucidate the
      mechanism of postprandial endothelial dysfunction and to identify early biomarkers
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Endothelial dysfunction (ED) is a hallmark for the initial stage of vascular dysfunction and
      has been associated with diet-related disorders such as cardiovascular disease. This makes
      prevention of ED an important health target. From previous studies we know that a high-fat
      (HF) meal (challenge) impairs postprandial endothelial function (EF). Current studies only
      evaluated the effect of a HF meal on Flow Mediated Dilatation (FMD), a measure of macro
      vascular EF. This methodology (FMD) however, is time consuming and large variations in
      reproducibility are reported in literature. The question remains whether other types of
      macro- and micro vascular EF measurements can be used to observe ED after a HF meal that are
      more accurate, faster and easier to perform. In addition, it is know that the postprandial
      phase results in activation of leukocytes. This activation of leukocytes is likely to
      contribute to ED, but the exact underling mechanism remains unclear.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">February 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Macrovascular local arterial stiffness by echo-tracking</measure>
    <time_frame>0, 3, 6 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Macrovascular regional arterial stiffness by tonometry</measure>
    <time_frame>0, 3, 6 h</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Macrovascular circulation by flow mediated dilatation</measure>
    <time_frame>0, 3, 6h</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Microvascular circulation by iontophoresis/laser doppler</measure>
    <time_frame>0, 3, 6h</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>PBMC gene expression profiles</measure>
    <time_frame>0, 1, 2, 3, 5, 6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Leukocyte activation markers</measure>
    <time_frame>0, 3, 6h</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cytokine profiles</measure>
    <time_frame>0, 1, 2, 3, 5, 6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>known plasma markers of ED</measure>
    <time_frame>0, 1, 2, 3, 5, 6 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Cardiovascular Disease</condition>
  <condition>Endothelial Dysfunction</condition>
  <arm_group>
    <arm_group_label>High fat meal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A high fat milkshake containing 95g of fat</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control meal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Milkshake comparable with a normal breakfast</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High fat meal 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A high fat milkshake containing 95g of fat</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High fat meal 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A high fat milkshake containing 95g of fat</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control meal 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Milkshake comparable with a normal breakfast</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control meal 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Milkshake comparable with a normal breakfast</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>high fat meal</intervention_name>
    <description>milkshake containing 95g fat</description>
    <arm_group_label>High fat meal</arm_group_label>
    <arm_group_label>High fat meal 2</arm_group_label>
    <arm_group_label>High fat meal 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>control meal</intervention_name>
    <description>milkshake comparable with a normal breakfast</description>
    <arm_group_label>Control meal</arm_group_label>
    <arm_group_label>Control meal 2</arm_group_label>
    <arm_group_label>Control meal 3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male, caucasian

        Exclusion Criteria: • Allergic to cow milk or dairy products

          -  Body mass index (BMI) &lt; 18 or &gt; 25 kg/m2

          -  Urine glucose concentrations outside normal ranges (&gt;0,25 g/l)

          -  Fasting blood glucose outside the normal range (3 - 5.5 mmol/L)

          -  Tobacco smoking

          -  Taking medication or food supplements.

          -  Received inoculations within 2 months of starting the study or planned to during the
             study

          -  Donated or intended to donate blood from 2 months before the study till two months
             after the study

          -  Blood Hb values below 8.4 mmol/L

          -  Diagnosed with any long-term medical condition (e.g., diabetes, hemophilia,
             cardiovascular disease, anemia, gastrointestinal disease, renal failure)

          -  High blood pressure (systolic BP&gt; 140 mmHg and/or diastolic BP&gt;90 mmHg)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Müller, Prof.Dr</last_name>
    <role>Study Chair</role>
    <affiliation>Chair Department of human nutrition NMG group</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lydia A Afman, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Senior scientist department Human Nutrition Wageningen University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wageningen universiteit division of human</name>
      <address>
        <city>Wageningen</city>
        <state>Gelderland</state>
        <zip>6703HD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 3, 2008</study_first_submitted>
  <study_first_submitted_qc>October 3, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2008</study_first_posted>
  <last_update_submitted>September 28, 2009</last_update_submitted>
  <last_update_submitted_qc>September 28, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 29, 2009</last_update_posted>
  <responsible_party>
    <name_title>Wageningen universiteit department of human nutrition</name_title>
    <organization>Wageningen universiteit</organization>
  </responsible_party>
  <keyword>endothelium,</keyword>
  <keyword>postprandial</keyword>
  <keyword>microvascular</keyword>
  <keyword>macrovascular</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

